R. Bastús

发表

nduction chemotherapy with cisplatin and emcitabine followed by concurrent chemoradiation ith twice-weekly gemcitabine in unresectable stage II non-small cell lung cancer : Final results of a hase II study

I. Bover, J. Solé, J. Terrassa, 2008 .

Induction chemotherapy with cisplatin and gemcitabine followed by concurrent chemoradiation with twice-weekly gemcitabine in unresectable stage III non-small cell lung cancer: final results of a phase II study.

I. Bover, M. Algara, J. Solé, 2008, Lung cancer.

Bladder cancer in the textile industry.

M. Kogevinas, J. Sunyer, X. Bonfill, 2000, Scandinavian journal of work, environment & health.

Low-dose β-lactam plus amikacin in febrile neutropenia: cefepime vs. piperacillin/tazobactam, a randomized trial

J. Martí, J. Garau, L. Cirera, 2010, European Journal of Clinical Microbiology & Infectious Diseases.

Follow-up of breast cancer stages I and II. An analysis of some common methods.

E. Alba, R. Bastús, J. Piera, 1987, European Journal of Cancer and Clinical Oncology.

[Pancoast's syndrome: difficulties in its diagnosis].

I. Bonaventura, M. Aguilar, R. Bastús, 1993, Revista clinica espanola.

Malignant Pleural Mesothelioma: The Last 8 Years of Experience in Our Area

S. Call, J. Benítez, R. Bastús, 2018, Archivos de Bronconeumología (English Edition).

Phase I-II study of paclitaxel, cisplatin, and gemcitabine in advanced transitional-cell carcinoma of the urothelium. Spanish Oncology Genitourinary Group.

J. Baselga, J. J. de la Cruz, J. Carles, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG).

J. Carles, M. Margelí, J. Aparicio, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Risk-adapted treatment in clinical stage I testicular seminoma: the third Spanish Germ Cell Cancer Group study.

X. G. Del Muro, M. Margelí, J. Aparicio, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Risk-Adapted Approach to Patients with Stage I Seminoma according to the Status of Rete Testis: The Fourth Spanish Germ Cell Cancer Group Study

S. Ochenduszko, J. Aparicio, E. Gonzalez-Billalabeitia, 2018, Oncology.

Patterns of relapse and treatment outcome after active surveillance or adjuvant carboplatin for stage I seminoma: a retrospective study of the Spanish Germ Cell Cancer Group

S. Ochenduszko, J. Aparicio, I. Durán, 2020, Clinical and Translational Oncology.

[Extrabronchial small-cell carcinoma: apropos 6 cases].

L. Cirera, F. Tresserra, G. González-Pont, 1993, Medicina clinica.

Long-term survival in small cell carcinoma of the lung.

C. Pallarés, L. de Andrés, R. Bastús, 1987, European journal of cancer & clinical oncology.

Risk-adapted management for patients with clinical stage I seminoma: the Second Spanish Germ Cell Cancer Cooperative Group study.

J. Carles, B. Mellado, L. Paz-Ares, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic and Predictive Factors for Renal Cell Carcinoma

E. Gallardo, N. Sala, C. Suarez, 2018, Targeted Oncology.

Small Cell Carcinoma of the Urinary Bladder Treated with Chemotherapy and Radiotherapy: Results in Five Cases

G. González, L. Cirera, R. Bastús, 1999, European Urology.

Screening for epidermal growth factor receptor mutations in lung cancer.

Mariano Provencio, Miguel Angel Molina, Bartomeu Massuti, 2009, The New England journal of medicine.

Anticipatory nausea and vomiting: prevalence and predictors in chemotherapy patients.

E. Alba, L. de Andrés, R. Bastús, 1989, Oncology.

Leptomeningeal Carcinomatosis in a Patient With Clinical Stage III Lung Adenocarcinoma and Sudden Neurological Impairment

L. Cirera, R. Bastús, M. Campayo, 2018, Archivos de Bronconeumología (English Edition).

Leptomeningeal Carcinomatosis in a Patient With Clinical Stage III Lung Adenocarcinoma and Sudden Neurological Impairment.

L. Cirera, R. Bastús, M. Campayo, 2018, Archivos de bronconeumologia.

[Incidence of urinary bladder cancer in an industrialized area of Spain].

X. Bonfill, G. Úrrutia, C. Serra, 2002, Gaceta sanitaria.

Routine positron emission tomography (PET) and selective mediastinoscopy is as good as routine mediastinoscopy to rule out N2 disease in non-small cell lung cancer (NSCLC).

R. Rami-Porta, L. Cirera, M. Simó, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Breast cancer, locally advanced and metastatic

L. Holmberg, O. Nanni, S. Barni, 2012 .

Screening for epidermal growth factor receptor mutations in lung cancer.

L. Paz-Ares, R. Rosell, M. Taron, 2009, The New England journal of medicine.